This is a routine procedural filing with no standalone trading signal. Monitor for the definitive proxy statement from XOMA Royalty (expected within weeks) which will contain the actual vote recommendation and updated deal timeline.
Price Chart
Executive Summary
Ligand Pharmaceuticals filed a DEFA14A (also structured as an 8-K) to report Amendment No. a minor administrative amendment to its pending acquisition of XOMA Royalty acquisition. The amendment adds XOMA Royalty Holdings Corporation (HoldCo), a newly formed wholly-owned subsidiary of XOMA Royalty, as a party to the Merger Agreement solely to effect a Nevada holding company reorganization. No economic terms, deal value, or closing conditions changed. This is a procedural step in the deal progression with no standalone.
Key Facts
- May 16, 2026: XOMA Royalty, Ligand, and Merger Sub entered into Amendment No. 1 to the Merger Agreement
- Amendment adds XOMA Royalty Holdings Corporation (HoldCo) as a party to facilitate a holding company reorganization under NRS 92A
- No changes to deal consideration, structure, or closing conditions disclosed
- Original Merger Agreement was dated April 27, 2026 — amendment is a routine step in the deal mechanics
Financial Impact
No financial impact — purely structural amendment to add HoldCo as a party for a holding company reorganization
Risk Factors
- Deal closing remains subject to XOMA Royalty stockholder approval and regulatory clearance as previously disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-228006 |
| Document: 0001193125-26-228006-index-headers.html | 0001193125-26-228006 |
| Document: 0001193125-26-228006-index.html | 0001193125-26-228006 |
| Document: 0001193125-26-228006.txt | 0001193125-26-228006 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 18, 2026 23w ago | DEFA14A | — | awaiting T+5 | — | — |
May 18, 2026 23w ago | 8-K | — | awaiting T+5 | — | — |
Apr 30, 2026 25w ago | 8-K | — | awaiting T+5 | — | — |
Apr 27, 2026 26w ago | DEFA14A | $0.0400 $0.0500 | ▲ +25.00% | ▲ +24.32% | — |
Apr 27, 2026 26w ago | 8-K | $0.0400 $0.0500 | ▲ +25.00% | ▲ +24.32% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers